Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Vitality Biopharma, Inc.
  6. Company
    VBIO   US92849B1070

VITALITY BIOPHARMA, INC.

(VBIO)
SummaryQuotesChartsNewsCompanyFinancials 
Business Summary
Vitality Biopharma, Inc. is a biopharmaceutical company. The Company is focused on developing the cannabinoid pharmaceutical prodrugs also known as cannabosides. The Company utilizes its enzymatic bioprocessing technologies to discover its cannabosides are cannabinoid-glycoside prodrugs. The Company’s cannabosides products include glycosylated tetrahydrocannabinol (THC), cannabidiol (CBD), cannabidivarin (CBDV) and cannabinol (CBN). Its THC-glycoside (VBX-100) prodrug is developed for the treatment of gastrointestinal diseases, including inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). IBD is a frequently chronic inflammatory condition where parts of the digestive system become inflamed from an overactive immune response. IBS is a functional gastrointestinal disorder that commonly affects the large intestine and is characterized by abdominal cramping, diarrhea, constipation and pain.

Number of employees : 3 people.
Managers
Name Title Age Since
Michael Cavanaugh Chief Executive Officer & Director 46 2019
Richard McKilligan Controller, Chief Financial & Accounting Officer 57 -
Brandon Zipp, Dr. Chief Science Officer 39 2020
Edward F. Feighan Executive Chairman 72 2019
Richard F. Celeste Independent Director 82 2019
Members of the board
Name Title Age Since
Edward F. Feighan Executive Chairman 72 2019
Michael Cavanaugh Chief Executive Officer & Director 46 2019
Richard F. Celeste Independent Director 82 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 50,700,147 33,668,376 66.4% 0 0.0% 66.4%
Shareholders
NameEquities%
Joseph E. Loconti 13,153,063 25.9%
Edward F. Feighan 2,690,917 5.31%
Michael Cavanaugh 879,791 1.74%
KLCM Advisors, Inc. 148,000 0.29%
Brandon Zipp 64,000 0.13%
Richard McKilligan 10,000 0.020%
FNY Capital Management LP 4,000 0.0079%
CapFinancial Partners LLC 3,440 0.0068%
Steward Partners Investment Advisory LLC 2,400 0.0047%
First National Bank of Mount Dora Trust Services 1,000 0.0020%
Company contact information
Vitality Biopharma, Inc.
1901 Avenue of the Stars
2nd floor
Los Angeles, CA 90067

Phone : +1.530.231.7800
Web : http://www.vitality.bio
Brand Portfolio
In partnership withAllbrands.markets
More brands of Vitality Biopharma, Inc.
Sector Bio Therapeutic Drugs